z-logo
open-access-imgOpen Access
Current use of ivermectin in dermatology, tropical medicine, and COVID-19: An update on pharmacology, uses, proven and varied proposed mechanistic action
Author(s) -
Sinu Rose Mathachan,
Kabir Sardana,
Ananta Khurana
Publication year - 2021
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_298_21
Subject(s) - ivermectin , medicine , covid-19 , hydroxychloroquine , drug , clinical pharmacology , antiparasitic agent , antiparasitic , broad spectrum , pharmacology , drug reaction , drug repositioning , dermatology , intensive care medicine , veterinary medicine , pathology , chemistry , combinatorial chemistry , disease , infectious disease (medical specialty)
Ivermectin is a broad-spectrum antiparasitic drug with anti-inflammatory, anti-viral, anti-bacterial, and anti-tumor effects. In this review, we discuss the history, pharmacology, multimodal actions, indications in dermatology and tropical medicine, therapeutic and prophylactic use of ivermectin in COVID-19, safety, adverse effects, special considerations, and drug interactions of ivermectin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here